The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
H. Watz, P. Calverley, P. Chanez, R. Dahl, M. Decramer, B. Disse, H. Finnigan, A. Kirsten, R. Rodriguez-Roisin, K. Tetzlaff, L. Towse, E. Wouters, H. Magnussen (Grosshansdorf, Ingelheim, Tübingen, Germany; Liverpool, Berkshire, United Kingdom; Marseille, France; Odense, Denmark; Leuven, Belgium; Barcelona, Spain; Maastricht, Netherlands)
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Session: New clinical evidence for asthma and COPD treatments
Session type: Thematic Poster Session
Number: 2423
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Watz, P. Calverley, P. Chanez, R. Dahl, M. Decramer, B. Disse, H. Finnigan, A. Kirsten, R. Rodriguez-Roisin, K. Tetzlaff, L. Towse, E. Wouters, H. Magnussen (Grosshansdorf, Ingelheim, Tübingen, Germany; Liverpool, Berkshire, United Kingdom; Marseille, France; Odense, Denmark; Leuven, Belgium; Barcelona, Spain; Maastricht, Netherlands). The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study. Eur Respir J 2014; 44: Suppl. 58, 2423
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: